Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Intervalo de año de publicación
1.
PLoS One ; 14(10): e0223578, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-31596896

RESUMEN

INTRODUCTION: Bexarotene, a retinoid X receptor agonist, improves cognition in murine models of Alzheimer's disease (AD). This study evaluated the effects of bexarotene on pathological and electrophysiological changes in very old triple transgenic AD mice (3xTg-AD mice). METHODS: 24-month-old 3xTg-AD mice were treated with bexarotene (100 mg/kg/day for 30 days). The Morris water maze was used to evaluate spatial memory; immunofluorescence and confocal microscopy were used to evaluate pathological changes; and in vivo electrophysiological recordings were used to evaluate basal transmission and plasticity in the commissural CA3-CA1 pathway. RESULTS: In addition to cognitive improvement, bexarotene-treated 3xTg-AD mice were found to have 1) reductions of astrogliosis and reactive microglia both in cortex and hippocampus; 2) increased ApoE expression restricted to CA1; 3) increased number of cells co-labeled with ApoE and NeuN; 4) recovery of NeuN expression, suggesting neuronal protection; and, 5) recovery of basal synaptic transmission and synaptic plasticity. DISCUSSION: These results indicate that bexarotene-induced improvement in cognition is due to multiple changes that contribute to recovery of synaptic plasticity.


Asunto(s)
Enfermedad de Alzheimer/tratamiento farmacológico , Bexaroteno/uso terapéutico , Hipocampo/efectos de los fármacos , Fármacos Neuroprotectores/uso terapéutico , Enfermedad de Alzheimer/genética , Animales , Apolipoproteínas E/metabolismo , Bexaroteno/farmacología , Proteínas de Unión al ADN/metabolismo , Femenino , Gliosis , Hipocampo/crecimiento & desarrollo , Hipocampo/metabolismo , Hipocampo/fisiopatología , Masculino , Aprendizaje por Laberinto , Ratones , Proteínas del Tejido Nervioso/metabolismo , Neuroglía/metabolismo , Plasticidad Neuronal , Fármacos Neuroprotectores/farmacología , Transmisión Sináptica
2.
Epigenomics ; 10(11): 1365-1382, 2018 11.
Artículo en Inglés | MEDLINE | ID: mdl-30324800

RESUMEN

OBJECTIVE: To study DNA methylation patterns of cortical pyramidal layers susceptible to late-onset Alzheimer's disease (LOAD) neurodegeneration. METHODS: Laser-assisted microdissection to select pyramidal layers' cells in frontal cortex of 32 human brains (18 LOAD) and Infinium DNA Methylation 450K analysis were performed to find differential methylated positions and regions, in addition to the corresponding gene set functional enrichment analyses. RESULTS: Differential hypermethylation in several genomic regions and genes mainly in HOXA3, GSTP1, CXXC1-3 and BIN1. The functional enrichment analysis revealed genes significantly related to oxidative-stress and synapsis. CONCLUSION: The present results indicate the differentially methylated genes related to neural projections, synapsis, oxidative stress and epigenetic regulator genes and represent the first epigenome of cortical pyramidal layers in LOAD.


Asunto(s)
Enfermedad de Alzheimer/genética , Metilación de ADN , Lóbulo Frontal/metabolismo , Proteínas Adaptadoras Transductoras de Señales/genética , Anciano , Anciano de 80 o más Años , Proteínas de Unión al ADN/genética , Femenino , Gutatión-S-Transferasa pi/genética , Proteínas de Homeodominio/genética , Humanos , Captura por Microdisección con Láser , Masculino , Proteínas Nucleares/genética , Estrés Oxidativo , Células Piramidales/metabolismo , Transmisión Sináptica , Transactivadores , Proteínas Supresoras de Tumor/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA